Article ID Journal Published Year Pages File Type
5702680 Urologic Oncology: Seminars and Original Investigations 2017 9 Pages PDF
Abstract
Down-regulation of PRKDC attenuates tumor progression in PCa. PRKDC may potentially be a prognostic biomarker in PCa.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Oncology
Preview
Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer
Authors
, , ,